A Single-Blind, Pilot Study to Determine the Tolerability and Safety of TD-1211 in Subjects With Opioid-Induced Constipation
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2014
At a glance
- Drugs Axelopran (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors Theravance
- 26 Apr 2013 Results will be presented at the 32nd Annual Scientific Meeting of the American Pain Society (APS) in May 2013.
- 26 Apr 2013 Status changed from active, no longer recruiting to completed, as indicated in a Theravance media release.
- 06 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials